Phathom Pharmaceuticals, Inc. (PHAT) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $22.60M | +183.4% |
| 2024 | $7.97M | +4674.3% |
| 2023 | $167.0K | — |
| 2022 | $0 | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $22.60M | +183.4% |
| 2024 | $7.97M | +4674.3% |
| 2023 | $167.0K | — |
| 2022 | $0 | — |